May 31 Approaching, page-9

Until UNS can show it can cut the 20-25million losses per qtr I think I will put their financing at 3 qtrs before a weak balance sheet means they are back to beating the grass for the next means of increasing shareholder value

Given that Amgen coming on board and lending UNS cash has meant nothing to the SP I cant see management changes doing anything for the SP in the short to mid term.

Getting a device on the shelf is 1 on my list of what will help SP and credability